Regulation
Adagio Medical seeks FDA PMA for ventricular ablation system
Adagio Medical submitted a premarket approval application to the FDA for its vCLAS ventricular ablation system, a catheter-based device designed for treatment of ventricular arrhythmias. The PMA filing represents a key regulatory milestone for the company's ablation technology.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network